tirzepatide for anti inflammatory vs. Semaglutide: Which Is Better You ? tirzepatide anti inflammatory Tirzepatide for

Falk, D

Participants on placebo achieved a total mean weight loss of 3.8% (4.1 kg or 9.0 lb.) from study entry over 84 weeks

A recent multicenter retrospective study published in 2024 further validated tirzepatides real-world efficacy in OSAS management

Ethical Approval This study was conducted in accordance with relevant guidelines and regulations, including the principals of the Declaration of Helsinki of 1964 and its later amendments

Repeated breathing disruptions and drops in blood oxygen can cause excessive daytime sleepiness, impaired concentration and memory loss, and the condition carries associations with hypertension, ischemic heart disease, heart failure, depression and type 2 diabetes